We reported earlier this week that Houston, TX-based wireless cardiac monitoring startup, eCardio had monitored about 20,000 patients to date. Today, CardioNet, one of the first wireless cardiac companies to go to market has announced that it just passed 300,000 patients monitored by its Mobile Cardiac Outpatient Telemetry (MCOT) service.
“With 300,000 patients having now benefited from our MCOT service, it is evident that an increasing number of physicians view real-time, 24/7 monitoring of cardiac arrhythmias as crucial to identifying and preventing life-threatening cardiac-related events such as stroke,” Randy Thurman, CardioNet Chairman, President and CEO, stated in a company release. “The continued availability and adoption of MCOT also brings value to the entire healthcare continuum as it enables physicians to manage arrhythmias before they manifest into more severe conditions that demand significantly greater costs and resources to treat.”
One of CardioNet’s biggest competitors is LifeWatch, which has an exclusive deal with Verizon Wireless. San Diego-based Corventis also recently launched a competing MCOT service after gaining regulatory approval from the FDA earlier this year.
For more on CardioNet read the press release